Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR-T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback